Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: A bivariate meta-analysis

Chest

Volumn 147, Issue 4, 2015, Pages 1043-1062

  Kohn, Christine G ^a   Mearns, Elizabeth S ^b,c   Parker, Matthew W ^d   Hernandez, Adrian V ^e,f   Coleman, Craig I ^b,c  

^a UNIVERSITY OF SAINT JOSEPH   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d HARTFORD HOSPITAL   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f INSTITUTO NACIONAL DE SALUD   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL PREDICTION RULE; COMPUTER ASSISTED TOMOGRAPHY; EUROPEAN SOCIETY OF CARDIOLOGY; GENEVA TOOL; GLOBAL REGISTRY OF ACUTE CORONARY EVENTS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; ICD-9; INSTRUMENT VALIDATION; LOW RISK PULMONARY EMBOLISM DECISION; LUNG EMBOLISM; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY SEVERITY INDEX; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; CAUSE OF DEATH; DECISION SUPPORT SYSTEM; HEALTH; META ANALYSIS; PROCEDURES; SURVIVAL RATE; TRENDS;

CAUSE OF DEATH; DECISION SUPPORT TECHNIQUES; GLOBAL HEALTH; HUMANS; PROGNOSIS; PULMONARY EMBOLISM; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84927142795     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1888     Document Type: Article

References (80)

1. Silverstein MD , Heit JA , Mohr DN , Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998; 158 (6): 585-593.
2. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000; 83 (5): 657-660.
3. Kearon C , Akl EA , Comerota AJ , et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9Thed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 ;141(2-suppl):e419S-e494S.
4. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998; 279 (6): 458-462.
5. Van Bellen B , Prins M , Bamber L , Wang M , Lensing AWA. Reduction in initial length of stay with rivaroxaban single-drug regimen versus LMWH-VKA standard of care: findings from the EINSTEIN trial program. Presented at 54th Annual American Society of Hematology Meeting; December 10, 2012; Atlanta, GA.
6. Zondag W , Kooiman J , Klok FA , Dekkers OM , Huisman MV. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis. Eur Respir J. 2013; 42 (1): 134-144.
7. Aujesky D , Obrosky DS , Stone RA , et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005; 172 (8): 1041-1046.
8. Jiménez D , Aujesky D , Moores L , et al; RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010; 170 (15): 1383-1389.
9. Zondag W , den Exter PL , Crobach MJ , et al; Hestia Study Investigators. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost. 2013; 109 (1): 47-52.
10. Ozsu S , Abul Y , Orem A , et al. Predictive value of troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism. Multidiscip Respir Med. 2013; 8 (1): 34.
11. Lankeit M, Jiménez D, Kostrubiec M, et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011; 124 (24): 2716-2724.
12. Nordenholz K, Ryan J, Atwood B, Heard K. Pulmonary embolism risk stratification: pulse oximetry and pulmonary embolism severity index. J Emerg Med. 2011; 40 (1): 95-102.
13. Sam A , Sánchez D , Gómez V , et al. The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism. Eur Respir J. 2011; 37 (4): 762-766.
14. Sánchez D , De Miguel J , Sam A , et al. The effects of cause of death classification on prognostic assessment of patients with pulmonary embolism. J Thromb Haemost. 2011; 9 (11): 2201-2207.
15. Chan CM , Woods C , Shorr AF. The validation and reproducibility of the pulmonary embolism severity index. J Thromb Haemost. 2010; 8 (7): 1509-1514.
16. Vanni S , Nazerian P , Pepe G , et al. Comparison of two prognostic models for acute pulmonary embolism: clinical vs right ventricular dysfunctionguided approach. J Thromb Haemost. 2011; 9 (10): 1916-1923.
17. Aujesky D , Obrosky DS , Stone RA , et al. A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med. 2006; 166 (2): 169-175.
18. Aujesky D , Perrier A , Roy PM , et al. Validation of a clinical prognostic model to identify low-risk patients with pulmonary embolism. J Intern Med. 2007; 261 (6): 597-604.
19. Barra S , Paiva L , Providencia R , Fernandes A , Nascimento J , Marques AL. LR-PED rule: low risk pulmonary embolism decision rule-a new decision score for low risk pulmonary embolism. Thromb Res. 2012; 130 (3): 327-333.
20. Bova C , Pesavento R , Marchiori A , et al; TELESIO Study Group. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up. J Thromb Haemost. 2009; 7 (6): 938-944.
21. Chan CM , Woods CJ , Shorr AF. Comparing the pulmonary embolism severity index and the prognosis in pulmonary embolism scores as risk stratification tools. J Hosp Med. 2012; 7(1): 22-27.
22. Choi WH , Kwon SU , Jwa YJ , et al. The pulmonary embolism severity index in predicting the prognosis of patients with pulmonary embolism. Korean J Intern Med. 2009; 24 (2): 123-127.
23. Davies CW , Wimperis J , Green ES , et al. Early discharge of patients with pulmonary embolism: a two-phase observational study. Eur Respir J. 2007; 30 (4): 708-714.
24. Dentali F , Riva N , Turato S , et al. Pulmonary embolism severity index accurately predicts long-term mortality rate in patients hospitalized for acute pulmonary embolism. J Thromb Haemost. 2013; 11 (12): 2103-2110.
25. Donzé J , Le Gal G , Fine MJ , et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008; 100 (5): 943-948.
26. Erkens PM , Gandara E , Wells PS , et al. Does the Pulmonary Embolism Severity Index accurately identify low risk patients eligible for outpatient treatment? Thromb Res. 2012; 129 (6): 710-714.
27. Ferrer M , Morillo R , Elías T , et al. Validation of two clinical prognostic models in patients with acute symptomatic pulmonary embolism. Arch Bronconeumol. 2013; 49 (10): 427-431.
28. Jakobsson C , Jiménez D , Gómez V , Zamarro C , Méan M , Aujesky D. Validation of a clinical algorithm to identify low-risk patients with pulmonary embolism. J Thromb Haemost. 2010; 8 (6): 1242-1247.
29. Jiménez D , Yusen RD , Otero R , et al. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest. 2007; 132 (1): 24-30.
30. Kukla P, Bryniarski L, Dlugopolski R, et al. Acute pulmonary embolism registry in the Malopolska region-clinical course. Kardiol Pol. 2009; 67 (7): 735-741.
31. Labyk A, Ciurzyński M, Jankowski K, et al. Acute pulmonary embolism: analysis of consecutive 353 patients hospitalised in a single centre. A 3-year experience. Kardiol Pol. 2012; 70 (1): 15-22.
32. Lankeit M , Gómez V , Wagner C , et al; on behalf of the Instituto Ramón y Cajal de Investigación Sanitaria Pulmonary Embolism Study Group. A strategy combining imaging and laboratory biomarkers in comparison with a simplified clinical score for risk stratification of patients with acute pulmonary embolism. Chest. 2012; 141 (4): 916-922.
33. Nendaz MR , Bandelier P , Aujesky D , et al. Validation of a risk score identifying patients with acute pulmonary embolism, who are at low risk of clinical adverse outcome. Thromb Haemost. 2004; 91 (6): 1232-1236.
34. Palmieri V , Gallotta G , Rendina D , et al. Troponin I and right ventricular dysfunction for risk assessment in patients with nonmassive pulmonary embolism in the Emergency Department in combination with clinically based risk score. Intern Emerg Med. 2008; 3 (2): 131-138.
35. Paiva LV , Providencia RC , Barra SN , Faustino AC , Botelho AM , Marques AL. Cardiovascular risk assessment of pulmonary embolism with the GRACE risk score. Am J Cardiol. 2013; 111 (3): 425-431.
36. Pollack CV , Schreiber D , Goldhaber SZ , et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report ofeMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol. 2011; 57 (6): 700-706.
37. Post F , Mertens D , Sinning C , Peetz D , Münzel T. Decision for aggressive therapy in acute pulmonary embolism: implication ofelevated troponin T. Clin Res Cardiol. 2009; 98 (6): 401-408.
38. Sanchez O , Trinquart L , Planquette B , et al. Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism. Eur Respir J. 2013; 42 (3): 681-688.
39. Singanayagam A , Chalmers JD , Scally C , et al. Right ventricular dilation on CT pulmonary angiogram independently predicts mortality in pulmonary embolism. Respir Med. 2010; 104 (7): 1057-1062.
40. Soares TH , de Bastos M , de Carvalho BV , et al. Prognostic value of computed tomographic pulmonary angiography and the pulmonary embolism severity index in patients with acute pulmonary embolism. Blood Coagul Fibrinolysis. 2013; 24 (1): 64-70.
41. Spencer FA , Goldberg RJ , Lessard D , et al. Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism Study. Circ Cardiovasc Qual Outcomes. 2010; 3 (4): 390-394.
42. Spirk D , Aujesky D , Husmann M , et al. Cardiac troponin testing and the simplified Pulmonary Embolism Severity Index. The SWIss Venous Thrombo Embolism Registry (SWIVTER). Thromb Haemost. 2011; 106 (5): 978-984.
43. Subramaniam RM , Mandrekar J , Blair D , Peller PJ, Karalus N. The Geneva prognostic score and mortality in patients diagnosed with pulmonary embolism by CT pulmonary angiogram. J Med Imaging Radiat Oncol. 2009; 53 (4): 361-365.
44. Venetz C, Jiménez D, Mean M, Aujesky D. A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost. 2011; 106 (3): 423-428.
45. Zondag W , Vingerhoets LM , Durian MF , et al; Hestia Study Investigators. Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective ofright ventricular function. J Thromb Haemost. 2013; 11 (4): 686-692.
46. Zwierzina D , Limacher A , Méan M , et al. Prospective comparison of clinical prognostic scores in elder patients with a pulmonary embolism. J Thromb Haemost. 2012; 10 (11): 2270-2276.
47. Goldhaber SZ. Modern treatment of pulmonary embolism. Eur Respir J Suppl. 2002; 35: 22s-27s.
48. Torbicki A, van Beek EJR, Charbonnier B, et al. Guidelines on diagnosis and management of acute pulmonary embolism. Task Force on Pulmonary Embolism, European Society of Cardiology. Eur Heart J. 2000; 21 (16): 1301-1336.
49. Dalen JE , Hirsh J. Introduction: antithrombotic therapy-the evolving consensus: 1985 to 1998. Chest. 1998; 114 (5-suppl): 439S-440S.
50. Geersing GJ, Bouwmeester W, Zuithoff P, Spijker R , Leefl ang M , Moons KG. Search filters for finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews. PLoS ONE. 2012; 7 (2): e32844.
51. Whiting PF , Rutjes AWS , Westwood ME , et al; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155 (8): 529-536.
52. McGinn TG , Guyatt GH , Wyer PC , Naylor CD , Stiell IG , Richardson WS; Evidence-Based Medicine Working Group. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA. 2000; 284 (1): 79-84.
53. Reitsma JB , Glas AS , Rutjes AW , Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005; 58 (10): 982-990.
54. Macaskill P , Gatsonis C , Deeks J , Harbord R , Takwoingi Y. Chapter 10: analysing and presenting results. In: Deeks JJ , Bossuyt PM , Gatsonis C , eds. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 1.0.The Cochrane Collaboration; 2010. http://srdta.cochrane.org/. Accessed October 2014.
55. Trikalinos TA , Balion CM , Coleman CI , et al. Chapter 8: meta-analysis of test performance when there is a "gold standard." J Gen Intern Med. 2012; 27 (suppl 1): S56-S66.
56. Altman DG , Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003; 326 (7382): 219.
57. Higgins JPT , Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. http://srdta.cochrane.org/.Accessed October 2014.
58. Doebler P , Holling H. Meta-analysis of diagnostic accuracy (mada). R package version 0.5.4. http://CRAN.R-project.org/package 5 mada. Published 2013. Accessed September 2014.
59. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Ann Intern Med. 2009 ;151:264-269.
60. Aujesky D, Roy PM, Le Manach CP, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J. 2006;27(4):476-481.
61. Torbicki A , Perrier A , Konstantinides S , et al; ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Manage ment of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008; 29 (18): 2276-2315.
62. Wicki J , Perrier A , Perneger TV , Bounameaux H , Junod AF. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost. 2000; 84 (4): 548-552.
63. Zondag W , Mos IC , Creemers-Schild D , et al; Hestia Study Investigators. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost. 2011; 9 (8): 1500-1507.
64. Uresandi F , Otero R , Cayuela A , et al. A clinical prediction rule for identifying short-term risk of adverse events in patients with pulmonary thromboembolism [in Spanish]. Arch Bronconeumol. 2007; 43 (11): 617-622.
65. Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011; 378 (9785): 41-48.
66. Aujesky D , Smith KJ , Cornuz J , Roberts MS. Cost-effectiveness of lowmolecular-weight heparin for treatment of pulmonary embolism. Chest. 2005; 128 (3): 1601-1610.
67. Ng AC , Chow V , Yong AS , Chung T , Kritharides L. Prognostic impact of the Charlson comorbidity index on mortality following acute pulmonary embolism. R espiration. 2013; 85 (5): 408-416.
68. Erkens PM , ten Cate H , Büller HR , Prins MH. Benchmark for time in therapeutic range in venous thromboembolism: a systematic review and meta-analysis. PLoS ONE. 2012; 7 (9): e42269.
69. van Bellen B , Bamber L , Correa de Carvalho F, Prins M, Wang M, Lensing AW. Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism. Curr Med Res Opin. 2014; 30 (5): 829-837.
70. Moher D , Pham B , Klassen TP , et al. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol. 2000; 53 (9): 964-972.
71. Jüni P , Holenstein F , Sterne J , Bartlett C , Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol. 2002; 31 (1): 115-123.
72. Kobberoe Sogaard K , Schmidt M , Pedersen L , Horváth-Puhó E , Toft Sorensen H. 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation. 2014 ;130(10):829-836.
73. Yamaki T , Nozaki M , Sakurai H , Takeuchi M , Soejima K , Kono T. Presence of lower limb deep vein thrombosis and prognosis in patients with symptomatic pulmonary embolism: preliminary report. Eur J Vasc Endovasc Surg. 2009; 37 (2): 225-231.
74. Volschan A , Albuquerque D , Tura BR , et al; EMEP (Estudo Multicentrico de Embolia Pulmonar) investigators. Predictors of hospital mortality in hemodynamically stable patients with pulmonary embolism. Arq Bras Cardiol. 2009; 93 (2): 135-140.
75. Agterof MJ , Schutgens RE , Moumlin , et al. A prognostic model for short term adverse events in normotensive patients with pulmonary embolism. Am J Hematol. 2011; 86 (8): 646-649.
76. den Exter PL , Gómez V , Jiménez D , et al; Registro Informatizado de la Enfermedad TromboEmbólica (RIETE) Investigators. A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. Chest. 2013; 143 (1): 138-145.
77. Kline JA , Roy PM , Th an MP , et al. Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool. Thromb Res. 2012; 129 (5): e194-e199.
78. Leal SRN , Dores H , Rosario I , et al. Acute pulmonary embolism: development ofearly and long term morbidity and mortality risk score. Eur Heart J. 2010; 31 (suppl 1): 625.
79. Murugappan M , Johnson JA , Gage BF , et al. HOme Management Exclusion (HOME) criteria for initial treatment of acute pulmonary embolism [abstract]. Am J Respir Crit Care Med. 2008; 177: A182.
80. Limone BL , Hernandez AV , Michalak D , Bookhart BK , Coleman CI. Timing ofrecurrent venous thromboembolism early after the index event: a metaanalysis ofrandomized controlled trials. Thromb Res. 2013; 132 (4): 420-426.